MRCB Downgraded Amid Limited Catalyst, Slower Earnings Recovery
MRCB is expected to face continued earnings pressure after posting a 2Q26 core net loss of RM61.5 million, with revenue down 41% year-on-year. HLIB Research downgraded the stock to 'Hold' with a lower target price, citing limited catalysts and slower earnings recovery.